Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.024 | 0.7 |